NuVasive Announces $100 Million Share Repurchase Program

Go back to NuVasive Announces $100 Million Share Repurchase Program

NuVasive (NUVA) PT Lowered to $70 at Canaccord Genuity

October 25, 2017 8:48 AM EDT

Canaccord Genuity lowered its price target on NuVasive (NASDAQ: NUVA) to $70.00 (from $75.00) while maintaining a Buy rating.

Analyst Kyle Rose said while concerns about the underlying health of the US spine market are likely to keep more cautious investors on the... More